The pharmacokinetics and safety of vonoprazan in adolescents and children with gastroesophageal reflux disease

20260 citationsJournal Articlehybrid Open Access

Authors

Darcy J. Mulford · Li Creative Technologies (United States)

David A. Gremse · University of South Alabama

Yu‐Ming Chang · Li Creative Technologies (United States)

Eckhard Leifke · Li Creative Technologies (United States)

Thomas Wagner

Axel Facius

Galen Witt · Li Creative Technologies (United States)

Abstract

Exposures of vonoprazan in adolescents and children were nearly identical to exposures observed in adults, confirming the appropriateness of vonoprazan 10 and 20 mg doses in a pediatric population.

Topics & Keywords

Gastroesophageal reflux and treatments Pediatric Urology and Nephrology Studies Gastrointestinal motility and disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Pediatric Gastroenterology and Nutrition

DOI: 10.1002/jpn3.70368

Field-Weighted Citation Impact: 0.00